Newsroom – Strait Access Technologies

Cape Town Company Achieves First-in-Human Clinical Milestone in the USA with Innovative Medical Device

Strait Access Technologies recently announced the successful first-in-human use of the CenterFlow® post-TEVAR stent-graft balloon moulding catheter, marking a significant milestone for the company.

The SAT Production Facility

EACTS Live-in-a-box

Transcatheter valve with hollow-balloon for rheumatic aortic incompetence. Presentation by Jacques Scherman.

Strait Access Technologies Achieves First-in-Human Milestone with CenterFlow® Following TEVAR

CenterFlow® achieves first-in-human success. Our FDA-cleared balloon molding catheter demonstrates excellent stability and preserved perfusion during post-TEVAR procedures—advancing the standard of care in aortic endovascular repair.